Voyager Therapeutics to Present at the Jefferies Healthcare Conference
June 01 2023 - 7:00AM
Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company
dedicated to breaking through barriers in gene therapy and
neurology, today announced that CEO Alfred W. Sandrock, Jr., M.D.,
Ph.D., will present at the Jefferies Healthcare Conference on
Thursday, June 8, 2023, at 3:30 p.m. ET.
A webcast of the presentation may be accessed from the Investors
section of Voyager’s website at www.voyagertherapeutics.com. A
replay of the webcast will be archived on the Company's website for
at least 30 days.
About Voyager TherapeuticsVoyager
Therapeutics (Nasdaq: VYGR) is a biotechnology company dedicated to
breaking through barriers in gene therapy and neurology. The
potential of both disciplines has been constrained by delivery
challenges; Voyager is leveraging cutting-edge expertise in capsid
discovery and deep neuropharmacology capabilities to address these
constraints. Voyager’s TRACER AAV capsid discovery platform has
generated novel capsids with high target delivery and blood-brain
barrier penetration at low doses, potentially addressing the narrow
therapeutic window associated with conventional gene therapy
delivery vectors. This platform is fueling alliances with Pfizer
Inc., Novartis and Neurocrine Biosciences as well as multiple
programs in Voyager’s own pipeline. Voyager’s pipeline includes
wholly-owned and collaborative preclinical programs in Alzheimer’s
disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease,
and Friedreich’s Ataxia, with a focus on validated targets and
biomarkers to enable a path to rapid potential proof-of-biology.
For more information, visit www.voyagertherapeutics.com.
Voyager Therapeutics® is a registered trademark, and TRACER™ is
a trademark, of Voyager Therapeutics, Inc.
ContactsInvestorsInvestors@vygr.com
Andrew Funderburkafunderburk@kendallir.com
MediaPeg
Rusconiprusconi@vergescientific.com
Voyager Therapeutics (NASDAQ:VYGR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Voyager Therapeutics (NASDAQ:VYGR)
Historical Stock Chart
From Jul 2023 to Jul 2024